NP / PA
Heart 2 Heart Care Clinic, LLC
Heart 2 Heart Care Clinic, LLC was paid $365K by Medicaid between Jul 2019 and Dec 2024, across 104 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoHEART 2 HEART CARE CLINIC, LLC
BATON ROUGE, LA 70806
BATON ROUGE, LA 70806
33aNPI1215396775assigned 02/12/2016
33bProvider typePrimary Care Nurse Practitioner
28Total paid$365K
24GClaims84,194
24DCodes billed104
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Primary Care Nurse Practitioner providers in Louisiana
Rank by total paid#4 of 22
Median peer was paid$16K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,245 | $12K | |
| 2020 | 7,337 | $73K | |
| 2021 | 8,125 | $54K | |
| 2022 | 16,935 | $93K | |
| 2023 | 27,930 | $88K | |
| 2024incomplete | 22,622 | $46K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 6,962 | 3,768 | $162K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 3,004 | 1,861 | $109K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 2,839 | 1,667 | $38K |
| 96127 | 4.5% | 7,930 | 2,940 | $17K | |
| H0049 | Alcohol and/or drug screening | 1.2% | 3,381 | 1,491 | $5K |
| 96160 | 1.2% | 6,205 | 2,287 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 90 | 68 | $3K |
| A4663 | Blood pressure cuff only | <1% | 889 | 379 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 73 | 67 | $2K |
| 81002 | <1% | 1,800 | 1,099 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 192 | 146 | $2K |
| 99401 | <1% | 411 | 167 | $2K |
92 more codes
| 99402 | <1% | 153 | $2K | |
| 99051 | <1% | 240 | $2K | |
| 99385 | <1% | 37 | $2K | |
| 90688 | <1% | 108 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 898 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $774.54 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 641 | $750.11 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 18 | $701.04 |
| 99490 | Ccm add 20min | <1% | 149 | $688.54 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 557 | $682.69 |
| 0001A | <1% | 19 | $676.52 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $616.80 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 578 | $431.29 |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 167 | $420.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 245 | $362.62 |
| 90686 | <1% | 42 | $337.61 | |
| 80074 | <1% | 213 | $329.86 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 342 | $289.96 |
| 57150 | <1% | 16 | $283.84 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 323 | $237.03 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 109 | $236.89 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 232 | $225.21 |
| 80053 | Comprehensive metabolic panel | <1% | 485 | $184.09 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $174.24 |
| 80061 | Lipid panel | <1% | 477 | $152.51 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 548 | $137.89 |
| 82962 | <1% | 78 | $133.92 | |
| 99417 | Prolong home eval add 15m | <1% | 58 | $105.06 |
| 98960 | <1% | 201 | $101.43 | |
| 0513F | <1% | 351 | $90.00 | |
| 99408 | <1% | 75 | $84.72 | |
| 83525 | <1% | 116 | $66.09 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 69 | $63.78 |
| 82607 | <1% | 127 | $60.02 | |
| 86592 | <1% | 253 | $49.37 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 224 | $39.87 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 195 | $35.36 |
| 82465 | <1% | 41 | $25.47 | |
| 83690 | <1% | 56 | $21.97 | |
| 82150 | <1% | 59 | $20.61 | |
| 84403 | <1% | 20 | $20.58 | |
| 2010F | <1% | 6,702 | $16.06 | |
| 82533 | <1% | 16 | $12.99 | |
| 3079F | <1% | 980 | $12.09 | |
| 86703 | <1% | 300 | $10.60 | |
| 3078F | <1% | 962 | $8.03 | |
| 3074F | <1% | 1,650 | $4.09 | |
| 3077F | <1% | 271 | $4.07 | |
| 3080F | <1% | 241 | $4.02 | |
| 3075F | <1% | 432 | $4.02 | |
| 99000 | <1% | 265 | $2.50 | |
| 82542 | <1% | 73 | $0.18 | |
| 87088 | <1% | 77 | $0.13 | |
| 84479 | <1% | 29 | $0.07 | |
| 84436 | <1% | 29 | $0.07 | |
| 82746 | <1% | 18 | $0.05 | |
| 87806 | <1% | 26 | $0.05 | |
| 86593 | <1% | 148 | $0.02 | |
| 80076 | <1% | 28 | $0.02 | |
| 1125F | 0% | 517 | $0.00 | |
| 2000F | 0% | 3,118 | $0.00 | |
| 1126F | 0% | 4,551 | $0.00 | |
| 1157F | 0% | 241 | $0.00 | |
| 96156 | 0% | 56 | $0.00 | |
| G9459 | Currently a tobacco non-user | 0% | 83 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 4,430 | $0.00 |
| 3008F | 0% | 1,472 | $0.00 | |
| 2001F | 0% | 1,895 | $0.00 | |
| 97802 | 0% | 291 | $0.00 | |
| 96150 | 0% | 29 | $0.00 | |
| 1170F | 0% | 139 | $0.00 | |
| 1123F | 0% | 212 | $0.00 | |
| 3011F | 0% | 20 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
| 1030F | 0% | 43 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 83 | $0.00 |
| 87340 | 0% | 13 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 2,228 | $0.00 |
| 1026F | 0% | 60 | $0.00 | |
| 1159F | 0% | 2,635 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 623 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,511 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 190 | $0.00 |
| 1160F | 0% | 88 | $0.00 | |
| 3502F | 0% | 78 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 1,027 | $0.00 |
| 91300 | 0% | 97 | $0.00 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 763 | $0.00 |
| 2014F | 0% | 2,962 | $0.00 | |
| 87631 | 0% | 23 | $0.00 | |
| 87660 | 0% | 37 | $0.00 | |
| 99072 | 0% | 82 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURRELL, SHETILA (OWNER/PROVIDER)